Principles and application of in-vitro drug pharmacokinetic simulation systems controlled by stepwise method

スポンサーリンク

概要

• 論文の詳細を見る
• 2001-09-01

著者

• OHYA Satoshi

  Biological Research Laboratories, Sankyo Co., Ltd.

• Ohya Satoshi

  Biological Research Laboratories Sankyo Co. Ltd.

• Shimada Kaoru

  Tokyo Senbai Hospital

• Shimada Kaoru

  Tokyo Metropolitan Yoikuin Geriatrics Hospital

• KUMAMOTO Yoshiaki

  Sapporo Medical University

関連論文

• Synthesis in Vitro Antifungal Activities of Novel Triazole Antifungal Agent CS-758
• CD8^+ T Lymphocyte Counts as an Adjunctive Predictor of Cytomegalovirus Retinitis in Patients with Acquired Immunodeficiency Syndrome
• In Vitro and Ex Vivo Anti-human Immunodeficiency Virus (HIV) Activities of a New Water-Soluble HIV Protease Inhibitor, R-87366,Containing (2S, 3S)-3-Amino-2-hydroxy-4-phenylbutanoic Acid
• Oral Vancomycin Hydrochloride Therapy for Postoperative Methicillin-Cephem-Resistant Staphylococcus aureus Enteritis
• Synthesis and Antifungal Activities of R-102557 and Related Dioxane-Triazole Derivatives
• Principles and application of in-vitro drug pharmacokinetic simulation systems controlled by stepwise method
• Inhibitory Activity to Protein Prenylation and Antifungal Activity of Zaragozic Acid D3, a Potent Inhibitor of Squalene Synthase Produced by the Fungus, Mollisia sp. SANK 10294
• Shock in Patients with Disseminated Intravascular Coagulation (DIC) : SYMPOSIUM ON TREATMENT OF SHOCK

スポンサーリンク